Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2023-06-09 12:39:50
OSLO, 9 June 2023: EXACT Therapeutics AS ("EXACT-Tx", "the Company" Euronext
Growth: EXTX) held its Annual General Meeting on June 9th 2023 at 10:30 CEST.
All proposed resolutions were approved.
Please find enclosed the minutes of the meeting including appendices. The
minutes will also be available on the the company website: www.exact-tx.com
ENDS
For more information, please contact:
Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com
John M. Edminson CFO
EXACT Therapeutics
Email: john.edminson@exact-tx.com
About EXACT-Tx
EXACT-Tx is a Norwegian clinical-stage precision health company developing a
technology platform for targeted therapeutic enhancement - Acoustic Cluster
Therapy (ACT®). ACT® is a proprietary formulation of microclusters (PS101)
activated by ultrasound for enhanced drug targeting deployed in multiple
indications to enhance the therapeutic efficacy of medicines through the use of
ultrasound-mediated drug delivery, for patients across multiple diseases.
www.exact-tx.com